Chronic low-dose lipid infusion in healthy patients induces markers of endothelial activation independent of its metabolic effects.

Elevated plasma triglyceride/free fatty acid (FFA) levels and insulin resistance may promote atherosclerosis through endothelial activation (ie, increased expression of intercellular adhesion molecule 1 [ICAM-1]/vascular adhesion molecule 1 [VCAM-1], and endothelin-1 [ET-1]) in patients with the metabolic syndrome, but this has never been directly tested. The authors measured endothelial activation and insulin sensitivity (euglycemic insulin clamp with [3-(3)H]-glucose) after a 4-day low-dose lipid infusion that elevated plasma FFA to levels observed in the metabolic syndrome in 20 lean, non-diabetic insulin-resistant subjects with a strong family history of type 2 diabetes mellitus (FH(+)) and 10 insulin-sensitive volunteers without a family history of type 2 diabetes mellitus (FH(-)). Low-dose lipid infusion reduced insulin sensitivity by approximately 25% in insulin-sensitive FH(-)controls but did not worsen preexisting insulin resistance in FH(+). Low-dose lipid infusion elevated plasma ICAM and VCAM levels similarly in both groups (approximately 12%-18%; P<.01 vs baseline), while plasma ET-1 levels increased more in FH(+)vs FH(-)(46% vs 10%; P=.005). Increased plasma FFA levels closely correlated with elevated ICAM (r=0.60; P<.01), VCAM, and ET-1 levels (r=0.39 and r=0.42, respectively; P<.05). Low-dose lipid infusion induces endothelial activation in both lean insulin-resistant (FH(+)) and insulin-sensitive (FH(-)) healthy patients, regardless of changes in insulin sensitivity. These results prove that even a modest lipid oversupply may be sufficient to trigger a deleterious endothelial response.

[1]  K. Cusi,et al.  55 METABOLIC AND ANTI-INFLAMMATORY BENEFICIAL EFFECTS OF PIOGLITAZONE (PIO) TREATMENT IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND THEIR ASSOCIATIONS WITH HISTOLOGICAL IMPROVEMENT , 2009 .

[2]  T. Rabelink,et al.  Endothelial function and dysfunction: testing and clinical relevance. , 2007, Circulation.

[3]  P. Reaven,et al.  Molecular and signaling mechanisms of atherosclerosis in insulin resistance. , 2006, Endocrinology and metabolism clinics of North America.

[4]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[5]  P. Libby,et al.  Vascular Biomarkers and Surrogates in Cardiovascular Disease , 2006, Circulation.

[6]  P. Reaven,et al.  Elevated Concentrations of Nonesterified Fatty Acids Increase Monocyte Expression of CD11b and Adhesion to Endothelial Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[7]  N. Bergeron,et al.  Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. , 2005, The Journal of clinical endocrinology and metabolism.

[8]  A. Ceriello,et al.  Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. , 2005, Atherosclerosis.

[9]  J. Pollock,et al.  Endothelin Mediates Superoxide Production and Vasoconstriction through Activation of NADPH Oxidase and Uncoupled Nitric-Oxide Synthase in the Rat Aorta , 2005, Journal of Pharmacology and Experimental Therapeutics.

[10]  C. Rondinone,et al.  Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats. , 2005, Metabolism: clinical and experimental.

[11]  D. Fulton,et al.  Endothelin-1 activation of JAK2 in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. , 2005, Vascular pharmacology.

[12]  C. Aybay,et al.  Endothelial activation and inflammation in prepubertal obese Turkish children. , 2005, Metabolism: clinical and experimental.

[13]  J. Wessale,et al.  Metabolic responses with endothelin antagonism in a model of insulin resistance. , 2005, Metabolism: clinical and experimental.

[14]  S. Necozione,et al.  Early activation of vascular endothelial cells and platelets in obese children. , 2005, The Journal of clinical endocrinology and metabolism.

[15]  F. Kim,et al.  Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβ , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[16]  A. Ergul,et al.  Vascular Dysfunction of Venous Bypass Conduits Is Mediated by Reactive Oxygen Species in Diabetes: Role of Endothelin-1 , 2005, Journal of Pharmacology and Experimental Therapeutics.

[17]  E. Benjamin,et al.  Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study , 2004, Circulation.

[18]  M. Yılmaz,et al.  Poor coronary collateral circulation is associated with higher concentrations of soluble adhesion molecules in patients with single-vessel disease , 2004, Coronary artery disease.

[19]  J. Kaski,et al.  Markers of Inflammation and Rapid Coronary Artery Disease Progression in Patients With Stable Angina Pectoris , 2004, Circulation.

[20]  R. DeFronzo,et al.  Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes. , 2004, American journal of physiology. Endocrinology and metabolism.

[21]  M. Yılmaz,et al.  Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis. , 2004, International journal of cardiology.

[22]  Yoko Ishiwata,et al.  The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. , 2004, Metabolism: clinical and experimental.

[23]  C. Semenkovich.  Fatty acid metabolism and vascular disease. , 2004, Trends in cardiovascular medicine.

[24]  Ambady Ramachandran,et al.  Markers of endothelial dysfunction in hyperglycaemic Asian Indian subjects. , 2004, Journal of diabetes and its complications.

[25]  M. Szczepańska,et al.  Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure , 2004, Pediatric Nephrology.

[26]  A. Aljada,et al.  Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.

[27]  Hui Chen,et al.  Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells* , 2003, Journal of Biological Chemistry.

[28]  R. DeFronzo,et al.  A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. , 2003, Diabetes.

[29]  A. Hevener,et al.  Chronic endothelin-1 treatment leads to insulin resistance in vivo. , 2003, Diabetes.

[30]  B. Zinker,et al.  Development of insulin resistance and endothelin-1 levels in the Zucker fatty rat. , 2003, Metabolism: clinical and experimental.

[31]  Alessandro Pontillo,et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.

[32]  M. Taskinen,et al.  Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. , 2003, Atherosclerosis.

[33]  R. Marfella,et al.  Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women , 2003 .

[34]  P. Ridker,et al.  Inflammatory bio‐markers and cardiovascular risk prediction , 2002, Journal of internal medicine.

[35]  A. Baron,et al.  Vascular function, insulin resistance and fatty acids , 2002, Diabetologia.

[36]  G. Paolisso,et al.  Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. , 2002, Journal of the American College of Cardiology.

[37]  A. Hamsten,et al.  Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation. , 2002, Metabolism: clinical and experimental.

[38]  E. Bonora,et al.  Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. , 2001, Diabetes care.

[39]  A. Hofman,et al.  Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. , 2001, The Journal of clinical endocrinology and metabolism.

[40]  Michael Karin,et al.  Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.

[41]  J. Olefsky,et al.  Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. , 2001, The Journal of clinical investigation.

[42]  H. Utsumi,et al.  High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. , 2000, Diabetes.

[43]  C. Polanczyk,et al.  Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia. , 2000, Diabetes care.

[44]  C. Kahn,et al.  Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. , 2000, The Journal of clinical investigation.

[45]  T Nakamura,et al.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.

[46]  G. Reaven,et al.  Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers. , 1999, The Journal of clinical endocrinology and metabolism.

[47]  F. Logerfo,et al.  Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. , 1999, Diabetes.

[48]  P. Ridker,et al.  Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[49]  G. Pacini,et al.  Endothelin‐1 infusion inhibits plasma insulin responsiveness in normal men , 1998, Journal of hypertension.

[50]  P. Grant,et al.  Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients , 1998, Diabetologia.

[51]  P. Ridker,et al.  Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men , 1998, The Lancet.

[52]  G. Desideri,et al.  Circulating endothelin-1 levels in obese patients with the metabolic syndrome. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[53]  T. W. Smith,et al.  Nitric oxide attenuates reoxygenation-induced ICAM-1 expression in coronary microvascular endothelium: role of NFkappaB. , 1997, Journal of molecular and cellular cardiology.

[54]  G. Ahlborg,et al.  Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. , 1997, Acta physiologica Scandinavica.

[55]  C. Juan,et al.  Endothelin-1 induces insulin resistance in conscious rats. , 1996, Biochemical and biophysical research communications.

[56]  A. Blann,et al.  Increased Levels of Soluble Adhesion Molecules in Type 2 (Non-Insulin Dependent) Diabetes mellitus Are Independent of Glycaemic Control , 1994, Thrombosis and Haemostasis.

[57]  R. DeFronzo,et al.  The Metabolic Profile of NIDDM Is Fully Established in Glucose-Tolerant Offspring of Two Mexican-American NIDDM Parents , 1992, Diabetes.

[58]  N. Iwasaki,et al.  Increased Plasma Endothelin in NIDDM Patients With Retinopathy , 1992, Diabetes Care.

[59]  I. Miyamori,et al.  Production of endothelin-1 from the mesenteric arteries of streptozotocin-induced diabetic rats. , 1991, Life sciences.

[60]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.